GlassScriptPhysician profile
Laureen A Diot
NPI 1235191370
$1,617.71
in general payments reported to CMS, 2019-2025
14 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $760 · 2023: $452 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.48 | 2022-2023 | |
| Amgen INC. | $150.00 | 2025 | Krystexxa |
| Medtronic, INC. | $131.14 | 2021 | |
| Viiv Healthcare Company | $125.00 | 2022 | |
| Organogenesis INC. | $124.99 | 2023 | Puraply Antimicrobial |
| Astrazeneca Pharmaceuticals LP | $124.89 | 2025 | Airsupra |
| Lilly USA, LLC | $120.67 | 2022 | |
| Gilead Sciences, INC. | $120.59 | 2022 | |
| Novo Nordisk INC | $120.18 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.50 | 2022 | |
| Biogen, INC. | $93.48 | 2023 | Spinraza |
| Advanced Oxygen Therapy INC. | $87.32 | 2023 | Topical Oxygen Chamber For Extremities |
| Janssen Pharmaceuticals, INC | $78.26 | 2022 | |
| Dexcom, INC. | $21.21 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laureen Diot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.